 |
|
|
| |
MAFLD is better than ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct antiviral agents
|
| |
| |
EASL 2023 Jue 23 Vienna
S. PELUSI1*, C. BIANCO1*,M. COLOMBO2, A. AGHEMO3,4, D. PRATI1, P. LAMPERTICO5,6,7, S. FAGIUOLI8,9, L. VALENTI1,6,10; for
the NAVIGATORE-Lombardia Network
*Equal contributors
|
| |
|
|
|
|
|
